Methylenecyclopropane Analogues of Nucleosides as Anti-herpes Agents

Advances in Antiviral Drug Design

Volumn 5, Issue , 2007, Pages 113-165

  Zemlicka, Jiri ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERPES; HERPESVIRIDAE;

EID: 40749114495     PISSN: 10758593     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1075-8593(06)05003-9     Document Type: Review

References (84)

1. Ambrose A.R., Zemlicka J., Kern E.R., Drach J.C., Gullen E., and Cheng Y.-C. Phosphoralaninate pronucleotides of pyrimidine methylenecyclopropane analogues of nucleosides: Synthesis and antiviral activity. Nucleosides Nucleotides Nucleic Acids 24 (2005) 1763-1774
2. Baldanti F., Sarasini A., Drach J.C., Zemlicka J., and Gerna G. Z-isomers of 2-hydroxymethylcyclopropylidenemethyladenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants. Antiviral Res. 56 (2002) 273-278
3. Bedard J., May S., Lis M., Tryphonas L., Drach J., Huffman J., Sidwell R., Chan L., Bowlin T., and Rando R. Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir. Antimicrob. Agents Chemother. 43 (1999) 557-567
4. Bidanset D.J., Hartline C.B., Collins D.J., Quenelle D.C., Chen X., Zemlicka J., and Kern E.R. In vitro and in vivo activity of the methylenecyclopropane analog, QYL-1064, against murine and human cytomegalovirus infections. Antiviral Res. 53 87 (2002) A61
5. Birnbaum K.B. Crystal structures of some acyclonucleosides with antiviral activity and related compounds. Acta Biochim. Pol. 43 (1996) 65-76
6. Birnbaum K.B., Stolarski R., and Shugar D. Structure and conformation of the cyclic phosphate of ganciclovir, a broad-spectrum antiviral agent. Biochim. Biophys. Acta 1200 (1994) 55-63
7. Bubenik M., Rej R., Nguyen-Ba N., Attardo G., Ouellet F., and Chan L. Novel nucleotide phosphonate analogues with potent antitumor activity. Bioorg. Med. Chem. Lett. 12 (2002) 3063-3066
8. Cahard D., McGuigan C., and Balzarini J. Aryloxy phosphoramidate triesters as protides. Mini-Rev. Med. Chem. 4 (2004) 371-381
9. Chen X., and Zemlicka J. Revision of absolute configuration of enantiomeric (methylenecyclopropyl)carbinols obtained from (R)-(-)- and (S)-(+)-epichlorohydrin and methylenetriphenylphosphorane. Implications for reaction mechanism and improved synthesis of antiviral methylenecyclopropane analogues of nucleosides. J. Org. Chem. 67 (2002) 286-289
10. Chen X., Kern E.R., Drach J.C., Gullen E., Cheng Y.-C., and Zemlicka J. Structure-activity relationships of (S, Z)-2-aminopurine methylenecyclopropane analogues of nucleosides. Variation of purine-6 substituents and activity against herpesviruses and hepatitis B virus. J. Med. Chem. 46 (2003) 1531-1537
11. Cheng C., Shimo T., Somekawa K., and Baba M. 9-Hydroxymethylcyclopropylidene-methylenyladenine: The design, facile synthesis, isomer separation and anti-HIV activities. Tetrahedron 54 (1998) 2031-2040
12. Cihlar T., McColl D., and Bischofberger N. Cellular transport of nucleotide analogs. In: Chu C.K. (Ed). Recent Advances in Nucleosides: Chemistry and Chemotherapy (2002), Elsevier, Amsterdam 477-503
13. Daluge S.M., Good S.S., Faletto M.B., Miller W.H., St. Clair M.H., Boone L.R., Tisdale M., Parry N.R., Reardon J.E., Dornsife R.E., Averett D.R., and Krenitsky T.A. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Antimicrob. Agents Chemother. 41 (1997) 1082-1093
14. Drach J.C., Fan B.Y., Ptak R.G., Breitenbach J.M., Borysko Z.K., Qiu Y.-L., and Zemlicka J. Selective activity of 2-hydroxymethylcyclopropylidenemethyl purines against human cytomegalovirus. Antiviral Res. 34 147 (1997) A83
15. Duke A.E., Smee D.F., Chernow M., Boehme R., and Matthews T.R. In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegalovirus. Antiviral Res. 6 (1986) 299-308
16. Faletto M.B., Miller W.H., Garvey E.P., St. Clair M.H., Daluge S.M., and Good S.S. Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89. Antimicrob. Agents Chemother. 41 (1997) 1099-1107
17. Germershausen J., Bostedor R., Liou R., Field A.K., Wagner A.F., MacCoss M., Tolman R.L., and Karkas J.D. Comparison of the modes of antiviral action of 2′-nor-deoxyguanosine and its cyclic phosphate, 2′-nor-cyclic GMP. Antimicrob. Agents Chemother. 29 (1986) 1025-1031
18. Guan H.-P., Ksebati M.B., Cheng Y.-C., Drach J.C., Kern E.R., and Zemlicka J. Spiropentane mimics of nucleosides: analogues of 2′-deoxyadenosine and 2′-deoxyguanosine. Synthesis of all stereoisomers, isomeric assignment, and biological activity. J. Org. Chem. 65 (2000) 1280-1290
19. Guan H.-P., Ksebati M.B., Kern E.R., and Zemlicka J. Approaches to unsaturated analogues of nucleosides comprising four- and six-membered rings. J. Org. Chem. 65 (2000) 5177-5184
20. Guan H.-P., Qiu Y.-L., Ksebati M.B., Kern E.R., and Zemlicka J. Synthesis of phosphonate derivatives of methylenecyclopropane nucleoside analogues by alkylation-elimination method and unusual opening of cyclopropane ring. Tetrahedron 58 (2002) 6047-6059
21. Hah J.H., Gil J.M., and Oh D.Y. The stereoselective synthesis of cyclopropylphosphonate analogs of nucleotides. Tetrahedron Lett. 40 (1999) 8235-8238
22. Harnden M.R., Jarvest R.L., Boyd M.R., Sutton D., and Vere Hodge R.A. Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption properties. J. Med. Chem. 32 (1989) 1738-1743
23. Hayashi S., Phadtare S., Zemlicka J., Matsukura M., Mitsuya H., and Broder S. Adenallene and cytallene: Acyclic nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA 85 (1988) 6127-6131
24. Hoffmann-Röder A., and Krause N. Synthesis and properties of allenic natural products and pharmaceuticals. Angew. Chem., Int. Ed. 43 (2004) 1196-1216
25. Holý A. Synthesis and biological activity of isopolar acyclic nucleotide analogs. In: Chu C.K. (Ed). Recent Advances in Nucleosides: Chemistry and Chemotherapy (2002), Elsevier, Amsterdam 167-238
26. Ivanov A.V., and Jasko M.V. Unsaturated acyclic nucleosides and nucleotides: synthesis and antiviral properties. In: Schinazi R.F., and Liotta D.C. (Eds). Frontiers in Nucleosides and Nucleic Acids (2004), IHL Press, Tucker, Georgia, USA 365-399
27. Kern E.R., Bidanset D.J., Hartline C.B., Yan Z., Zemlicka J., and Quenelle D.C. Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections. Antimicrob. Agents Chemother. 48 (2004) 4745-4753
28. Kern E.R., Kushner N.L., Hartline C.B., Williams-Aziz S.L., Harden E.A., Zhou S., Zemlicka J., and Prichard M.N. In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication. Antimicrob. Agents Chemother. 49 (2005) 1039-1045
29. Kitagawa O., Inoue T., Hirano K., and Taguchi T. Ionic iodocarbocyclization reactions of 4-alkenyl and 4-alkylmalonate derivatives. J. Org. Chem. 58 (1993) 3106-3112
30. Krenitsky T.A., Hall W.H., De Miranda P., Beauchamp L.M., Schaeffer H.J., and Whiteman P.D. 6-Deoxyacyclovir: A xanthine oxidase-activated prodrug of acyclovir. Proc. Natl. Acad. Sci. USA 81 (1984) 3209-3213
31. Kushner N.L., Williams S.L., Hartline C.B., Harden E.A., Bidanset D.J., Chen X., Zemlicka J., and Kern E.R. Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro. Nucleosides Nucleotides Nucleic Acids 22 (2003) 2105-2119
32. Lai M.-t., Liu L.-d., and Liu H.-w. Mechanistic study on the inactivation of general acyl-CoA dehydrogenase by a metabolite of hypoglycin A. J. Am. Chem. Soc. 113 (1991) 7388-7397
33. Le Corre M., Hercouet A., and Bessieres B. New convenient access to optically active methylidenecyclopropylcarbinols. J. Org. Chem. 59 (1994) 5483-5484
34. Leblond L., Attardo G., Hamelin B., Bouffard D.Y., Nguyen-Ba N., and Gourdeau H. BCH-1868 [(-)-2-R-dihydroxyphosphinoyl-5-(S)-(guanin-9′-yl-methyl) tetrahydrofuran]: A cyclic nucleoside phosphonate with antitumor activity. Mol. Cancer Ther. 1 (2002) 737-746
35. Letsinger R.L., Miller P.S., and Grams G.W. Selective N-debenzoylation of N,O-polybenzoylnucleosides. Tetrahedron Lett. 9 (1968) 2621-2624
36. Lima L.M., and Barreiro E.J. Bioisosterism: A useful strategy for molecular modification and drug design. Curr. Med. Chem. 12 (2005) 23-49
37. McGuigan C., Pathirana R.N., Mahmood N., Devine K.G., and Hay A.J. Aryl phosphate derivatives of AZT retain activity against HIV-1 in cell lines which are resistant to the action of AZT. Antiviral Res. 17 (1992) 311-321
38. Megati S., Goren Z., Silverton J.V., Orlina J., Nishimura H., Shirasaki T., Mitsuya H., and Zemlicka J. (R)-(-)- and (S)-(+)-Adenallene: synthesis, absolute configuration, enantioselectivity of antiretroviral effect, and enzymic deamination. J. Med. Chem. 35 (1992) 4098-4104
39. Nair V., Turner G.A., Buenger G.S., and Chamberlain S.D. New methodologies for the synthesis of C-2 functionalized hypoxanthine nucleosides. J. Org. Chem. 53 (1988) 3051-3057
40. Nguyen-Ba N., Turcotte N., Yuen L., Bedard J., Quimpere M., and Chan L. Identification of novel nucleotide phosphonate analogs with potent anti-HCMV activity. Bioorg. Med. Chem. Lett. 8 (1998) 3561-3566
41. Nguyen-Ba N., Chan L., Quimpere M., Turcotte N., Lee N., Mitchell H., and Bedard J. Design and SAR study of a novel class of nucleotide analogues as potent-HCMV agents. Nucleosides & Nucleotides 18 (1999) 821-827
42. Okuma K., Tanaka Y., Yoshihara K., Ezaki A., Koda G., Ohta H., Hara K., and Kashimura S. One-pot synthesis of enantiomerically pure (methylenecyclopropyl)carbinol: A key intermediate to the synthesis of the causative agent of Jamaican vomiting sickness. J. Org. Chem. 58 (1993) 5915-5917
43. Oliver S., Bubley G., and Crumpacker C. Inhibition of HSV-transformed murine cells by nucleoside analogs, 2′-NDG and 2′-nor-cGMP. Mechanism of inhibition and reversal by exogenous nucleosides. Virology 145 (1985) 84-93
44. Pankiewicz K.W. Fluorinated nucleosides. Carbohydr. Res. 327 (2000) 87-105
45. Phadtare S., and Zemlicka J. Nucleic acid derived allenols: Unusual analogues of nucleosides with antiretroviral activity. J. Am. Chem. Soc. 111 (1989) 5925-5931
46. Qin X., Chen X., Wang K., Polin L., Kern E.R., Drach J.C., Gullen E., Cheng Y.-C., and Zemlicka J. Synthesis, antiviral and antitumor activity of 2-substituted purine methylenecyclopropane analogues of nucleosides. Bioorg. Med. Chem. 14 (2006) 1247-1254
47. X. Qin, J. Zemlicka, unpublished results
48. Qiu Y.-L., and Zemlicka J. A new efficient synthesis of antiviral methylenecyclopropane analogs of purine nucleosides. Synthesis (1998) 1447-1452
49. Qiu Y.-L., Hempel A., Camerman N., Geiser F., Ptak R., Breitenbach J.M., Kira T., Li L., Gullen E., Cheng Y.-C., Drach J.C., and Zemlicka J. (R)-(-)- and (S)-(+)-synadenol: synthesis, absolute configuration, and enantioselectivity of antiviral effect. J. Med. Chem. 41 (1998) 5257-5264
50. Qiu Y.-L., Ksebati M.B., Ptak R.G., Fan B.Y., Breitenbach J.M., Lin J.-S., Cheng Y.-C., Kern E.R., Drach J.C., and Zemlicka J. (Z)- and (E)-2-((Hydroxymethyl)-cyclopropylidene)methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity. J. Med. Chem. 41 (1998) 10-23
51. Qiu Y.-L., Ptak R.G., Breitenbach J.M., Lin J.-S., Cheng Y.-C., Kern E.R., Drach J.C., and Zemlicka J. (Z)- and (E)-2-(Hydroxymethylcyclopropylidene)methylpurines and pyrimidines as antiviral agents. Antiviral Chem. Chemother. 9 (1998) 341-352
52. Qiu Y.-L., Ptak R.G., Breitenbach J.M., Lin J.-S., Cheng Y.-C., Drach J.C., Kern E.R., and Zemlicka J. Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides. Antiviral Res. 43 (1999) 37-53
53. Qiu Y.-L., Geiser F., Kira T., Gullen E., Cheng Y.-C., Ptak R.G., Breitenbach J.M., Drach J.C., Hartline C.B., Kern E.R., and Zemlicka J. Synthesis and enantioselectivity of the antiviral effects of (R,Z)-, (S,Z)-methylenecyclopropane analogues of purine nucleosides and phosphoralaninate prodrugs: influence of heterocyclic base, type of virus and host cells. Antiviral Chem. Chemother. 11 (2000) 191-202
54. Qiu Y.-L., Ksebati M.B., and Zemlicka J. Synthesis of (Z)- and (E)-9-[(2-hydroxy-ethylidene)cyclopropyl]adenine-new methylenecyclopropane analogues of adenosine and their substrate activity for adenosine deaminase. Nucleosides Nucleotides Nucleic Acids 19 (2000) 31-37
55. Robins M.J., and Uznanski B. Nucleic acid related compounds. 34. Non-aqueous diazotization with tert-butyl nitrite. Introduction of fluorine, chlorine, and bromine at C-2 of purine nucleosides. Can. J. Chem. 59 (1981) 2608-2611
56. Rozsondai B. Structural chemistry of cyclopropane derivatives. In: Rappoport Z. (Ed). The Chemistry of the Cyclopropyl Group, vol. 2 (1995), Wiley, New York 139-221 loc. cit. p. 187
57. Rybak R.J., Zemlicka J., Qiu Y.-L., Hartline C.B., and Kern E.R. Effective treatment of murine cytomegalovirus infections with methylenecyclopropane analogues of nucleosides. Antiviral Res. 43 (1999) 175-188
58. Saboulard D., Naesens L., Cahard D., Salgado A., Pathirana S., Velazquez C., McGuigan C., De Clercq E., and Balzarini J. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine. Mol. Pharmacol. 56 (1999) 693-704
59. Smith M.B., and March J. March's Advanced Organic Chemistry (2001), Wiley, New York 181 p
60. Smith M., Drummond G.I., and Khorana H.G. Cyclic phosphates. IV. Ribonucleoside-3′,5′ cyclic phosphates. A general method of synthesis and some properties. J. Am. Chem. Soc. 83 (1961) 698-706
61. Soli E.D., Manoso A.S., Patterson M.C., DeShong P., Favor D.A., Hirschmann R., and Smith III A.B. Azide and cyanide displacements via hypervalent silicate intermediates. J. Org. Chem. 64 (1999) 3171-3177
62. Sullivan V., Talarico C.L., Stanat C.S., Davis M., Coen D.M., and Biron K.K. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 358 (1992) 162-164
63. Tolman R.L., Field A.K., Karkas J.D., Wagner A.F., Germershausen J., Crumpacker C., and Scolnick E.M. 2′-nor-cGMP: a seco-cyclic nucleotide with powerful anti-DNA-viral activity. Biochem. Biophys. Res. Commun. 128 (1985) 1329-1335
64. Uchida H., Kodama E.N., Yoshimura K., Maeda Y., Kosalaraksa P., Maroun V., Qiu Y.-L., Zemlicka J., and Mitsuya H. In vitro anti-human immunodeficiency virus activities of Z- and E-methylenecyclopropane nucleoside analogues and their phosphoro-L-alaninate diesters. Antimicrob. Agents Chemother. 43 (1999) 1487-1490
65. Ullman E.F. Mechanism of hydrogenation of unsaturated cyclopropanes. J. Am. Chem. Soc. 81 (1959) 5386-5392
66. Van Draanen N.A., Freeman G.A., Short S.A., Harvey R., Jansen R., Szczech G., and Koszalka G.W. Synthesis and antiviral activity of 2′-deoxy-4′-thio purine nucleosides. J. Med. Chem. 39 (1996) 538-542
67. Wagner C.R., Iyer V.V., and McIntee E.J. Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides. Med. Res. Rev. 20 (2000) 417-451
68. Wang R., Ksebati M.B., Corbett T.H., Kern E.R., Drach J.C., and Zemlicka J. Methylene-gem-difluorocyclopropane analogues of nucleosides: synthesis, cyclopropene-methylenecyclopropane rearrangement, and biological activity. J. Med. Chem. 44 (2001) 4019-4022
69. Wang R., Corbett T.H., Cheng Y.-C., Drach J.C., Kern E.R., Mitsuya H., and Zemlicka J. Tryptophanyl phosphoramidates as prodrugs of synadenol and its E-isomer: synthesis and biological activity. Bioorg. Med. Chem. Lett. 12 (2002) 2467-2470
70. Wang R., Chen X., Drach J.C., Kern E.R., and Zemlicka J. Synthesis and biological activity of 2-aminopurine methylenecyclopropane analogues of nucleosides. Nucleosides Nucleotides Nucleic Acids 22 (2003) 135-144
71. Wang R., Harada S., Mitsuya H., and Zemlicka J. Inhibition of human immunodeficiency virus reverse transcriptase by synadenol triphosphate and its E-isomer. J. Med. Chem. 46 (2003) 4799-4802
72. Welch J.T., and Eswarakrishnan S. Fluorine in Bioorganic Chemistry (1991), John Wiley and Sons, New York
73. Yan Z., Kern E.R., Gullen E., Cheng Y.-C., Drach J.C., and Zemlicka J. Nucleotides and pronucleotides of 2,2-bis(hydroxymethyl)methylenecyclopropane analogues of purine nucleosides: Synthesis and antiviral activity. J. Med. Chem. 48 (2005) 91-99
74. Yan Z., Zhou S., Kern E.R., and Zemlicka J. Synthesis of methylenecyclopropane analogues of antiviral nucleoside phosphonates. Tetrahedron 62 (2006) 2608-2615
75. Zemlicka J. Allenols derived from nucleic acid bases-a new class of anti-HIV agents: Chemistry and biological activity. In: Chu C.K., and Baker D.C. (Eds). Nucleosides and Nucleotides as Antitumor and Antiviral Agents (1993), Plenum Press, New York 73-100
76. Zemlicka J. Antiviral nucleoside analogues with axial chirality. Nucleosides & Nucleotides 16 (1997) 1003-1012
77. Zemlicka J. Lipophilic phosphoramidates as antiviral pronucleotides. Biochim. Biophys. Acta 1587 (2002) 276-286
78. Zemlicka J. Unusual analogues of nucleosides: Chemistry and biological activity. In: Chu C.K. (Ed). Recent Advances in Nucleosides: Chemistry and Chemotherapy (2002), Elsevier, Amsterdam 327-357
79. Zemlicka J., and Chen X. Methylenecyclopropane analogues of nucleosides as antiviral agents. In: Schinazi R.F., and Liotta D.C. (Eds). Frontiers in Nucleosides and Nucleic Acids (2004), IHL Press, Tucker, Georgia, USA 267-307
80. J. Zemlicka, J.C. Drach, Methylenecyclopropane analogues of purine nucleosides as agents against drug-resistant cytomegalovirus, in: 228th American Chemical Society National Meeting, Philadelphia, Pennsylvania, August 22-26, Abstract MEDI 166, 2004
81. Zhu Y.-L., Pai B., Liu S.-H., Grove K.L., Jones B.C.N.M., Simons C., Zemlicka J., and Cheng Y.-C. Inhibition of replication of hepatitis B virus by cytallene in vitro. Antimicrob. Agents Chemother. 41 (1997) 1755-1760
82. Zhou S., Breitenbach J.M., Borysko K.Z., Drach J.C., Kern E.R., Gullen E., Cheng Y.-C., and Zemlicka J. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: Second-generation methylenecyclopropane analogues of nucleosides. J. Med. Chem. 47 (2004) 566-575
83. Zhou S., Kern E.R., Gullen E., Cheng Y.-C., Drach J.C., Matsumi S., Mitsuya H., and Zemlicka J. (Z)- and (E)-[2-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl-purines and -pyrimidines, a new class of methylenecyclopropane analogues of nucleosides: synthesis and antiviral activity. J. Med. Chem. 47 (2004) 6964-6972
84. Zhou S., and Zemlicka J. A new alkylation-elimination method for synthesis of antiviral fluoromethylenecyclopropane analogues of nucleosides. Tetrahedron 61 (2005) 7112-7116